Panel Discussion: Ensuring Cross-Functional Alignment to Safeguard IP Defensibility & Preserve Enterprise Value

• Strengthening collaboration between scientific, regulatory and legal teams to support robust patent scope and resilient trade-secret protection
• Coordinating disclosure timing, data generation, and regulatory positioning to strengthen valuation, diligence readiness, and lifecycle strategy
• Reducing risks in downstream enforcement, inventorship, and documentation risk in an increasingly AI-enabled R&D environment

Speakers:

Jason Tejani

General Counsel & Corporate Secretary 

Enveda Therapeutics, Inc.

Kady Bruce

Head of Intellectual Property

Crescent Biopharma

TJ Cradick

Principal & Fractional CSO

Gene Editing Frontiers

Rachel Herder

SVP, Legal & Alliance Management (Head of IP)

Mammoth Biosciences

Chris McAndrew

Partner, Patents & Innovations

Wilson Sonsini Goodrich & Rosati

Kathleen merriman

Executive Director, Intellectual Property

Umoja Biopharma